Managing Biotechnology

Information on the nature, trend and quality of biotechnology research, development, applications and management in a country is generally needed to improve policy decisions, guide future research and cooperation, civil society and general public knowledge, technology development agencies and to support public sector implementation of biotechnology research. Biotechnology has developed into a key innovation driver especially in the field of human healthcare. But as the biopharma...
More Description

Information on the nature, trend and quality of biotechnology research, development, applications and management in a country is generally needed to improve policy decisions, guide future research and cooperation, civil society and general public knowledge, technology development agencies and to support public sector implementation of biotechnology research. Biotechnology has developed into a key innovation driver especially in the field of human healthcare. But as the biopharma industry continues to grow and expand its reach, development costs are colliding with aging demographics and cost-containment policies of private and public payers. Concurrently, the development and increased affordability of sophisticated digital technologies has fundamentally altered many industries including healthcare. The field of biotechnology and the area of specialty pharmacy management continue to garner substantial attention from manufacturers, payers, analysts, and providers. This shift is raising concerns among payers and population managers about the associated financial burdens. This book entitled "Managing Biotechnology" offers biotechnology research and development covering activities that provide new knowledge, and the application of biotechnological techniques, biosafety and the regulation status of the biotechnology. It analyzes the strategies and key success factors for the financing, development, and commercialization of novel therapeutic products, including strategies for engagement with patients, physicians and healthcare payers. Throughout case studies provide researchers, corporate marketers, senior managers, consultants, financial analysts, and other professionals involved in the biotech sector with insights, ideas, and models. The aim is to provide an insight and update of the state of biotechnology in practice. It is also intended to highlight the strengths and weaknesses in biotechnology research and development capacity. This book will help scientists, policy makers and regulators and other stakeholders understand the state of biotechnology in the country and serve to guide scientists who are interested in doing research in untapped areas of biotechnology in the country.